Invention Grant
US08383612B2 Use of megestrol acetate for improving heart function and the treatment of heart insufficiency 有权
使用醋酸甲地孕酮改善心脏功能和治疗心功能不全

  • Patent Title: Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
  • Patent Title (中): 使用醋酸甲地孕酮改善心脏功能和治疗心功能不全
  • Application No.: US11667899
    Application Date: 2005-12-01
  • Publication No.: US08383612B2
    Publication Date: 2013-02-26
  • Inventor: Stefan Anker
  • Applicant: Stefan Anker
  • Applicant Address: US NY Spring Valley
  • Assignee: Par Pharmaceuticals, Inc.
  • Current Assignee: Par Pharmaceuticals, Inc.
  • Current Assignee Address: US NY Spring Valley
  • Agency: Saliwanchik, Lloyd & Eisenschenk
  • Priority: EP04028474 20041201
  • International Application: PCT/EP2005/012843 WO 20051201
  • International Announcement: WO2006/058748 WO 20060608
  • Main IPC: A01N45/00
  • IPC: A01N45/00 A61K31/56
Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
Abstract:
The present invention relates to improving the heart function, the survival and/or the treatment of heart insufficiency using megestrol acetate (Megace®; MA) in patients with heart insufficiency and after a myocardial infarction.
Information query
Patent Agency Ranking
0/0